Bilateral Papillary Thyroid Cancer and Associated Histopathologic Findings

被引:16
作者
Hwang, Euna [1 ,2 ]
Pakdaman, Michael N. [1 ,3 ]
Tamilia, Michael [5 ]
Hier, Michael P. [4 ]
Black, Martin J. [4 ]
Rochon, Louise [6 ]
Payne, Richard J. [4 ]
机构
[1] McGill Univ, Fac Med, Montreal, PQ, Canada
[2] Univ Ottawa, Dept Otolaryngol Head & Neck Surg, Ottawa, ON, Canada
[3] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[4] McGill Univ, Jewish Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3T 1E2, Canada
[5] McGill Univ, Jewish Gen Hosp, Dept Endocrinol, Montreal, PQ H3T 1E2, Canada
[6] McGill Univ, Jewish Gen Hosp, Dept Pathol, Montreal, PQ H3T 1E2, Canada
关键词
bilaterality; extrathyroidal extension; multifocality; papillary thyroid cancer; T staging; COMPLETION THYROIDECTOMY; TNM CLASSIFICATION; RISK GROUPS; CARCINOMA;
D O I
10.2310/7070.2010.090019
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To determine the incidence of bilateral papillary thyroid cancer (PTC) at total thyroidectomy (TT) and compare demographic risk factors (gender and age) and histopathologic findings (tumour size, extrathyroidal extension [ETE], T staging, and multifocality) between patients with PTC in both thyroid lobes and those with PTC limited to the ipsilateral lobe and/or isthmus. Design: Retrospective study. Setting: University teaching hospital. Methods: The pathology results of 1047 consecutive patients who underwent TT between 2002 and 2008 were reviewed. Statistical significance was obtained using the chi-square test. Main Outcome Measures: Incidence of bilateral PTC and its association with demographic risk factors and histopathologic findings. Results: Among 592 patients with PTC, 13.2% had bilateral PTC and 86.8% had unilateral and/or isthmian PTC. Bilaterality was present in 12.4% of women and 16.7% of men (p = .24) and in 12.9% of patients aged >= 45 years and 13.5% < 45 years (p = .83). Bilateral PTC was found in 12.6% of patients with a primary tumour <= 2 cm and 13.5% > 2 cm(p = .75); 23.6% of tumours with ETE demonstrated bilaterality compared to 9.7% without (p < .0001), and 8.7% of pT1 (p = .08), 9.2% of pT2 (p = .02), 23.0% of pT3 (p < .0001), and 12.5% of pT4 (p = .87) tumours were bilateral, respectively. Among bilateral PTC patients, 43.2% had multifoci in at least one lobe compared to 6.4% when nonbilateral (p < .0001). Conclusions: After TT, 13.2% of patients had bilateral PTC. No significant correlation was established between bilaterality and gender, age, and tumour size. Bilaterality was more commonly found in patients with ETE, advanced T stage, and at least one multifocal lobe.
引用
收藏
页码:284 / 287
页数:4
相关论文
共 20 条
[1]   Variables predicting distant metastases in thyroid cancer [J].
Clark, JR ;
Lai, P ;
Hall, F ;
Borglund, A ;
Eski, S ;
Freeman, JL .
LARYNGOSCOPE, 2005, 115 (04) :661-667
[2]   TOTAL THYROIDECTOMY FOR CANCER OF THE THYROID - SIGNIFICANCE OF INTRAGLANDULAR DISSEMINATION [J].
CLARK, RL ;
WHITE, EC ;
RUSSELL, WO .
ANNALS OF SURGERY, 1959, 149 (06) :858-866
[3]   Differentiated thyroid carcinoma:: The new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients [J].
Döbert, N ;
Menzel, C ;
Oeschger, S ;
Grünwald, F .
THYROID, 2004, 14 (01) :65-70
[4]   Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment [J].
Grigsby, Perry W. ;
Reddy, Rishindra M. ;
Moley, Jeffrey F. ;
Hall, Bruce L. .
SURGERY, 2006, 140 (06) :1043-1047
[5]  
Hay ID, 1998, SURGERY, V124, P958, DOI 10.1067/msy.1998.91825
[6]  
HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO
[7]  
2-I
[8]   Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation [J].
Kim, ES ;
Kim, TY ;
Koh, JM ;
Kim, YI ;
Hong, SJ ;
Kim, WB ;
Shong, YK .
CLINICAL ENDOCRINOLOGY, 2004, 61 (01) :145-148
[9]   Molecular analysis of multifocal papillary thyroid carcinoma [J].
Lin, Xiaoqi ;
Finkelstein, Sydney D. ;
Zhu, Bing ;
Silverman, Jan F. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2008, 41 (3-4) :195-203
[10]  
LOGERFO P, 1990, SURGERY, V108, P958